| Today's Big NewsOct 20, 2022 |
|
Greater Philadelphia offers bioscience companies space to develop in close proximity to its world-class University City research center and global airport. From production to R&D, learn how the region can be your launchpad for growth and expansion. 
|
|
| By Frank Diamond The Advisory Committee on Immunization Practices, a CDC advisory panel made up of medical and scientific experts, yesterday recommended that the COVID-19 vaccine become part of a child’s vaccination schedule. |
|
|
|
By Angus Liu In hot pursuit of Bristol Myers Squibb and 2seventy bio’s first-to-market Abecma, Johnson & Johnson and Legend Biotech’s CAR-T therapy Caryvkti has shown an encouraging sign of growth. |
By Nick Paul Taylor Pfizer may have dodged a bullet by walking away from AM-Pharma. The biotech, a onetime takeover target for the Big Pharma, has stopped a phase 3 clinical trial of its kidney injury candidate early after it failed an interim futility analysis. |
By Andrea Park A study published this week highlights yet another area of potential racial bias in healthcare: end-stage heart failure therapies, where white patients were found to receive life-extending treatments at distinctly higher rates compared to Black patients. |
By Kevin Dunleavy The CDC took the unusual step of going to Twitter on Wednesday to correct a Fox News report that claimed the agency was set to require schoolchildren to receive COVID-19 vaccines. Additionally, a CDC advisory committee voted unanimously to provide COVID shots for free to children under the age of 19 who can’t afford them. |
By Paige Minemyer Satisfaction with pharmacy benefit managers is on the decline, particularly among health plans, a new survey shows. |
By Gabrielle Masson Gene editing biotech Prime Medicine is turning up the heat, melting some of the frosty market waters with a $175 million IPO, one of the sector’s largest debuts this year, especially for a preclinical company with no human data to fuel fundraises. |
By Dave Muoio Occupancy, distance to a nursing station and easy line of sight into a hospital room may all be worth considering when assigning surgical patients a hospital room, according to a single-center study of nearly 4,000 surgical patients presented this week. |
By Zoey Becker After Pfizer launched to pandemic superstar status with its BioNTech-partnered COVID-19 vaccine, Comirnaty, the company has something to prove with its next few launches. And next year is setting up to be a pivotal year for the drugmaker, one that could feature up to 10 new launches, its CEO said. |
By James Waldron AbbVie is paying $255 million cash to acquire DJS Antibodies and the British biotech's platform for targeting transmembrane proteins. |
By Conor Hale The transaction for the Swiss manufacturer MedAlliance could total as much as $1.1 billion over the next seven years. |
By Andrea Park The FDA doled out a de novo clearance to the ScanNav Anatomy PNB device to help guide the precise delivery of peripheral nerve block injections. |
By Gabrielle Masson Gilead’s Kite Pharma has tied down a licensing deal for Refuge Biotechnologies’ gene expression platform in hopes of developing new blood cancer treatments, potentially setting flight to a new generation of CAR-Ts. |
Fierce podcasts Don't miss an episode |
| This week on "The Top Line," we talk about our latest analysis on the world’s most productive biopharmas. We also discuss Biogen's tumultuous year and who it is considering for a new CEO. |
|
|---|
|
|
|
Wednesday, October 26, 2022 | 1pm ET / 10am PT In this webinar, we’ll explore how incorporating telehealth genetic screening into clinical trials can accelerate patient identification, recruitment and engagement. Register now. 
|
|
eBook Improve patient engagement, adherence, and outcomes Sponsored by: Health Catalyst |
Whitepaper Electronic health records (EHR) and patient registries are both important sources of real-world evidence – but which is right for your needs? Sponsored by: Veradigm Health |
eBook Looking to implement a remote patient monitoring (RPM) program at your organization? Download the eBook from Health Catalyst to learn the essential components of successful RPM programs. Sponsored by: Health Catalyst |
eBook In this free guide, explore how Cloud Computing is enabling emerging biopharma organizations to decrease time-to-discovery in pursuit of breakthrough treatment modalities. Sponsored by: RCH Solutions |
eBook With real-world data playing a significant role in health care decisions, life sciences leaders need to maximize their data investments. The best place to start is right here, with our e-book on the four steps to a more coordinated, connected real-world data strategy. Sponsored by: Optum |
Whitepaper Learn the benefits of unlocking data insights across the healthcare and life sciences ecosystem. Sponsored by: NTT DATA |
Whitepaper Read about key factors and trends in RWE and how our data luminaries are the right partner to lead the way forward. Sponsored by: Lumanity |
Whitepaper SaaS LIMS from LabVantage Solutions Is Pre-Validated for Regulated Industries, Delivering Maximum Flexibility, Uptime, and Security. Sponsored by: LabVantage Solutions Inc. |
Whitepaper This paper is the first in a 4-part series focused on developing commercial models for gene therapies Sponsored by: Blue Matter, strategic consultants in the life sciences |
Whitepaper Advanced research requires advanced tools. The next-generation ELISA takes a fraction of the time to run eight analytes simultaneously while saving your sample volume. Sponsored by: Bio-Techne |
Video Can an optimized research process--including AI-powered workflow and process automation tools--help get breakthrough drugs to market faster? Sponsored by: Proscia |
Video Learn how a centralized platform for pathology images, metadata, and analysis results can connect previously siloed research initiatives and advance our collective understanding of tissue. Sponsored by: Proscia |
Whitepaper What is the most suitable dosage form technology for the Oral Delivery of Lipid-Based Formulations? Sponsored by: Catalent |
Research Learn more about how the versatility of Softgel Technology helped a customer with a volatile compound. Sponsored by: Catalent |
Whitepaper How can Lipid-Based Drug Delivery System help bring poorly soluble drugs to market? Sponsored by: Catalent |
Whitepaper Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care. Sponsored by: Catalent Biologics |
Webinar Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar. Sponsored by: Catalent Biologics |
Custom Resource Center Read through this library of resources to find out how you can strengthen innovation and efficiency, improve safety and quality, and prioritize resources to support your long-term goals. Sponsored by: JLL |
Whitepaper Clarus Therapeutics (Clarus) is a men’s specialty pharmaceutical company that partnered with Catalent to develop a unique and convenient drug delivery form for their hormone replacement therapy. Sponsored by: Catalent |
Whitepaper Learn more about how the transition from early to late phase of a small molecule program plays a pivotal role in a program’s ultimate success. Sponsored by: Catalent |
Whitepaper Explore how Thermo Scientific’s Process Liquid Preparation Services can help you plan for scalable buffer preparation. Sponsored by: Thermo Fisher Scientific |
eBook Orally Inhaled & Nasal Drug Delivery: A Pipeline of Opportunities Sponsored by: Catalent |
Whitepaper Did you know Catalent has newly expanded in-house capabilities spanning clinical and commercial scale manufacturing for DPIs, unit-dose, bi-dose and preserved multi-dose nasal sprays? Sponsored by: Catalent |
Whitepaper What are key considerations for intranasal delivery in the treatment of acute and chronic conditions? Sponsored by: Catalent |
| |
|
